Abstract
In CTPA only an enlarged pulmonary trunk is associated with an increased risk for mortality and recurrent VTE
Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Beenen reports other from Daiichi Sankyo, during the conduct of the study
Conflict of interest: Dr. Bossuyt has nothing to disclose.
Conflict of interest: Dr. Stoker reports other from Daiichi Sankyo, during the conduct of the study; other from Robarts Clinical Trials, outside the submitted work.
Conflict of interest: Dr. Middeldorp reports grants and personal fees from GSK, personal fees from Bayer, grants and personal fees from BMS-Pfizer, personal fees from Boehringer Ingelheim, grants and personal fees from Aspen, grants and personal fees from Daiichi Sankyo, personal fees from Portola, outside the submitted work.
This is a PDF-only article. Please click on the PDF link above to read it.
- Copyright ©ERS 2018